ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag funding culture policy

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
The Year in Pathogens
Molly Sharlach | Dec 28, 2014 | 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Observers Praise AIDS Report But Foresee Problems In Implementation
Steven Benowitz | May 12, 1996 | 10 min read
Problems In Implementation LOUD AND CLEAR: Attorney Lynda Dee stresses the need for communication among the institutes. When a federally appointed panel announced in March the results of its 15-month-long review of the United States government's AIDS research program, AIDS activists as well as scientists cheered. The National Institutes of Health's AIDS Research Program Evaluation Working Group's recommendations largely called for scrapping what the group saw as outdated and ineffective polic
Cloning Capsized?
Ted Agres | Aug 19, 2001 | 10+ min read
Biopharmaceutical researchers fear how pending federal legislation outlawing the cloning of human cells will restrict their abilities to find cures for major degenerative diseases.1,2 Some also see lawmakers impinging on established nonhuman cloning techniques essential for the discovery of new drugs and therapies. The source of all this worry? The US House of Representatives passed July 31 by a wide margin a bill (H.R. 2505) sponsored by Reps. David Weldon (R-Fla.) and Bart Stupak (D-Mich.) th
Mircens Help Bring First-Rate Science To The Third World
Robin Eisner | Sep 1, 1991 | 9 min read
Microbiologist J.K. Arap Keter is betting that some recently collected strains of the bacterial genus Rhizobium will soon join the family of other nonpolluting, inexpensive, microbial biofertilizers currently in use by thousands of East African farmers on legume crops. But first he and colleagues in the department of soil science at the University of Nairobi in Kenya must show that the new isolates can foster different plants' growth by helping the plants use nitrogen. After that, they must cu
Disappearing Disposal Sites Threaten Radioisotope Use
Rebecca Andrews | Apr 14, 1991 | 9 min read
AUTHOR: REBECCA ANDREWS, p.24 Walk into any biological research lab and you'll probably see the telltale, three-triangled symbol somewhere--on a storage cabinet, a trash can, a refrigerator--indicating that radioactive materials are present. Radioactive isotopes of common elements, most often used to quantify or track minute amounts of substances, are invaluable for research, and they will no doubt continue to be so in the foreseeable future. The benefits of this research notwithstanding, the
NASA Administrator Daniel Goldin Explains Timing, Purpose Of Big Changes At Agency
Daniel Goldin | Jan 10, 1993 | 8 min read
Editor's Note: Daniel Goldin, administrator of the National Aeronautics and Space Administration, was named to his $14 billion agency's top post seven months ago, having come from a position as vice president of TRW Inc.'s Space & Technology Group in Redondo Beach, Calif. In October, he initiated a series of major changes in the structure of NASA's space sciences research program. For example, Goldin has separated Mission to Planet Earth, the agency's Earth-observation satellite program, from t

Run a Search

ADVERTISEMENT